Evidence map›Paper›PMID 14694106›Full record

ArticleJournal of virology2004

Neutrality of the canonical NF-kappaB-dependent pathway for human and murine cytomegalovirus transcription and replication in vitro.

Chris A Benedict, Ana Angulo, Ginelle Patterson, Sukwon Ha, Huang Huang, Martin Messerle, Carl F Ware, Peter Ghazal

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. A clinically relevant murine model unmasks a "two-hit" mechanism for reactivation and dissemination of cytomegalovirus after kidney transplant.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2019
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. New cell-signaling pathways for controlling cytomegalovirus replication.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2014
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Chris A BenedictLa Jolla Institute of Allergy and Immunology, San Diego, California 92007, USA.
Ana Angulo
Ginelle Patterson
Sukwon Ha
Huang Huang
Martin Messerle
Carl F Ware
Peter Ghazal
La Jolla Institute for Immunology · USConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESScripps Research Institute · USUniversity of Edinburgh · GB

Funding

Anti-herpesvirus Signaling by LTalphabeta/LIGHT CytokinesR01AI048073 · NIAID · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI WARE, CARL F · 2001 to 2016
$7.0M
Lymphotoxin alpha Beta and LIGHT cytokine systemsR37AI033068 · NIAID · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI WARE, CARL F · 2003 to 2012
$4.2M
SURFACE LYMPHOTOXIN A/B COMPLEXESR01AI033068 · NIAID · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI WARE, CARL F · 1994 to 2002
$1.0M
EVOLVING SYNTHETIC POLYAMIDES AGAINST CYTOMEGALOVIRUSR21AI044851 · NIAID · SCRIPPS RESEARCH INSTITUTE · PI ANGULO, ANA · 2000 to 2000
$266k
TRANSCRIPTION FACTORS AND HUMAN CMV PATHOGENESISR01AI030627 · NIAID · SCRIPPS RESEARCH INSTITUTE · PI GHAZAL, PETER · 1997 to 1999
–
TRANSCRIPTION FACTORS AND HUMAN CMV PATHOGENESISR29AI030627 · NIAID · SCRIPPS RESEARCH INSTITUTE · PI GHAZAL, PETER · 1992 to 1996
–
NCI NIH HHS CA69831NIAID NIH HHS AI30627NIAID NIH HHS AI33068NIAID NIH HHS AI44851NIAID NIH HHS AI48073NIAID NIH HHS R01 AI033068NIAID NIH HHS R01 AI048073NIAID NIH HHS R37 AI033068Wellcome Trust
6 · The paper itself

Abstract

Cytomegalovirus (CMV) is known to rapidly induce activation of nuclear factor kappaB (NF-kappaB) after infection of fibroblast and macrophage cells. NF-kappaB response elements are present in the enhancer region of the CMV major immediate-early promoter (MIEP), and activity of the MIEP is strongly upregulated by NF-kappaB in transient-transfection assays. Here we investigate whether the NF-kappaB-dependent pathway is required for initiating or potentiating human and murine CMV replication in vitro. We show that expression of a dominant negative mutant of the inhibitor of NF-kappaB-alpha (IkappaBalphaM) does not alter the replication kinetics of human or mouse CMV in cultured cells. In addition, mouse embryo fibroblasts genetically deficient for p65/RelA actually showed elevated levels of MCMV replication. Mutation of all NF-kappaB response elements within the enhancer of the MIEP in a recombinant mouse CMV containing the human MIEP (hMCMV-ES), which we have previously shown to replicate in murine fibroblasts with kinetics equivalent to that of wild-type mouse CMV, did not negatively affect replication in fibroblasts. Taken together, these data show that, for CMV replication in cultured fibroblasts activation of the canonical NF-kappaB pathway and binding of NF-kappaB to the MIEP are dispensable, and in the case of p65 may even interfere, thus uncovering a previously unrecognized level of complexity in the host regulatory network governing MIE gene expression in the context of a viral infection.

Indexed as

Gene Expression Regulation, ViralTranscription, GeneticVirus ReplicationAnimalsCells, CulturedCytomegalovirusFibroblastsHumansImmediate-Early ProteinsMacrophagesMiceMuromegalovirusNF-kappa BResponse ElementsTranscription Factor RelAImmediate-Early ProteinsNF-kappa BTranscription Factor RelA

Identifiers

PMID14694106
PMCPMC368812
OpenAlexW2152705626

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.